BSE filing, NSE: FAIRCHEMOR. Summary written from the filing by ALFA Finder's alert engine.
Fairchem Organics Ltd: key numbers
- Share price
- ₹671.00
- Market cap
- ₹873.7 Cr
- Revenue (annual)
- ₹459.6 Cr
- Net profit (annual)
- ₹5.54 Cr
- P/E (TTM)
- 36.8×Sector 34.5×
- Promoter holding
- 63.26%+0.00% QoQ
- FII holding
- 6.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fairchem Organics Ltd
All →Fairchem Organics Earnings Call Transcript: Key Takeaways
Fairchem reported strong Q2 growth driven by lower raw material costs and reduced Chinese dumping.
Fairchem Organics Investor Presentation: Key Takeaways
Fairchem reported strong Q2FY27 results with 49.7% YoY revenue growth and 316.7% EBITDA growth. Strategy focuses on high-value oleo chemicals, export expansion, and waste-to-wealth manufacturing using renewable resources.
- Call
- Guides 25% growth
Fairchem Organics Q2 FY27 Results: Net Profit ₹10.2 Cr, Up 1175.0% YoY
Fairchem Organics Ltd reported revenue from operations of ₹166.9 Cr (+49.7% YoY) and net profit of ₹10.2 Cr (+1175.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹10.2 Cr · +1175.0% YoY
Fairchem Organics Other Announcement
Fairchem Organics Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
Fairchem Organics Earnings Call Transcript: Key Takeaways
Fairchem Organics shows a recovery in Q1 FY27, driven by higher price realizations and reduced Chinese dumping, though margins remain vulnerable to external geopolitical factors and raw material volatility.
- Call
- Guides 20% growth
Fairchem Organics Investor Presentation: Key Takeaways
Fairchem Organics reported strong Q1 FY27 results with revenue up 34.3% Y-o-Y to INR 1,761 Mn and EBITDA margins expanding to 10.16% driven by better domestic realization.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.